A direct, urine-based test to diagnose acute Lyme disease using actively secreted peptidoglycan as a biomarker
Ebohon, O.; Ahmad, S. S.; Dressler, J.; Rosario Perez, B. Y.; Ocius, K. L.; Pires, M. M.; Nigrovic, L. E.; Jutras, B. L.
Show abstract
Lyme disease is a growing and prominent human health problem caused by a group of spirochaetal bacteria that belong to the Borrelia genus. Persistent Lyme disease infection produces a multi-system disorder that may result in severe arthritis, carditis, neurological problems, and even death. Preventing severe disease requires immediate treatment, but current approaches to diagnose Lyme disease are indirect, serology-based assays that may fail early in infection. All Lyme disease-causing Borrelia species shed distinct and unique fragments of their peptidoglycan cell wall during growth. We exploited this fundamental biological process to develop an acute, urine-based diagnostic test. Using a cocktail of unique and highly specific monoclonal antibodies, our ELISA-mediated approach accurately reports on the status of an active, acute infection, in a laboratory animal model of Lyme disease, as well as humans. This rapid, simple, and innovative approach detects an active infection in as few as 3 days of transmission and in 88% of human patients yet to seroconvert--more than [~]2 weeks before serology would be positive.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Lipoproteome screening of the Lyme disease agent identifies novel inhibitors of antibody-mediated complement killing 95%
- Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy 93%
- The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence 93%
Similar papers in this journal
- Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection 93%
- Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay 92%
- T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity 91%
Similar papers in this journal
- A split ALFA tag-nanobody system for protein localization and proximity proteomics in mycobacteria 94%
- Proximity-labeling reveals novel host and parasite proteins at the Toxoplasma parasitophorous vacuole membrane 93%
- The glycoprotease CpaA secreted by medically relevant Acinetobacter species targets multiple O-linked host glycoproteins 93%
Similar papers in this journal
- A type-specific B cell epitope at the apex of Outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi 95%
- Identification of arginine phosphorylation in Mycolicibacterium smegmatis 93%
- Pharmacological inhibition of host pathways enhances macrophage killing of intracellular bacterial pathogens 92%
Similar papers in this journal
- SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster 91%
- Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts 91%
- Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.